Preformulation Study of the Inclusion Complex Irbesartan-β-Cyclodextrin
- 709 Downloads
The aim of the present work was to improve the solubility and dissolution profile of Irbesartan (IRB), a poorly water-soluble drug by formation of inclusion complex with β-cyclodextrin (βCD). Phase solubility studies revealed increase in solubility of the drug upon cyclodextrin addition, showing AL—type of graph with slope less than one indicating formation of 1:1 stoichiometry inclusion complex. The stability constant (K s) was found to be 104.39 M−1. IRB–βCD binary systems were prepared by cogrinding, kneading using alcohol, kneading using aqueous alcohol, and coevaporation methods. Characterization of the binary systems were carried out by differential scanning calorimetry, Fourier transform infrared spectroscopy, scanning electron microscopy, X-ray diffraction, and proton nuclear magnetic resonance. The dissolution profiles of inclusion complexes were determined and compared with those of IRB alone and physical mixture. Among the various methods, coevaporation was the best in which the solubility was increased and dissolution rate of the drug was the highest. The study indicated the usefulness of cyclodextrin technology to overcome the solubility problem of IRB.
Key wordsβ-cyclodextrin dissolution inclusion complex Irbesartan solubility
differential scanning calorimetry
Fourier transform infra-red spectroscopy
- 1H NMR
nuclear magnetic resonance
apparent stability constant
scanning electron microscopy
We would like to thank Dr. Vikram Jagtap, Aarti Drugs Ltd, India for kindly supplying the drug, Irbesartan, and Dr. M.R. Vora, Signet, India for kindly supplying β-cyclodextrin.
- 1.S. C. Sweetman. Martindale—The Complete Drug Reference, Pharmaceutical, London, 2005.Google Scholar
- 5.E. M. Martin Del Valle. Cyclodextrins and their uses: A review. Process. Biochem. 39:1033:1046 (2004).Google Scholar
- 7.T. Higuchi, and K. A. Connors. Phase solubility diagram. Adv. Anal. Chem. Instr. 4:117–212 (1965).Google Scholar